Toronto Dominion Bank
TXG icon

Toronto Dominion Bank’s 10x Genomics TXG Stock Holding History

Toronto Dominion Bank’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-22
Closed -$1K – 1795
2023
Q1 		$1K Hold
22
– – ﹤0.01% 1399
2022
Q4 		$1K Hold
22
– – ﹤0.01% 1486
2022
Q3 		$1K Buy
+22
New +$838 ﹤0.01% 1533
2022
Q2 		– Sell
-15,813
Closed -$1.2M – 1887
2022
Q1 		$1.2M Buy
15,813
+1,548
+11% +$135K ﹤0.01% 889
2021
Q4 		$2.13M Buy
14,265
+4,579
+47% +$701K ﹤0.01% 815
2021
Q3 		$1.41M Sell
9,686
-196
-2% -$33.7K ﹤0.01% 835
2021
Q2 		$1.94M Buy
9,882
+1,213
+14% +$220K ﹤0.01% 759
2021
Q1 		$1.57M Sell
8,669
-2,891
-25% -$499K ﹤0.01% 787
2020
Q4 		$1.64M Buy
+11,560
New +$1.68M ﹤0.01% 822

Other funds holding TXG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return

Toronto Dominion Bank's TXG Position: Q2 2023 in Review

Toronto Dominion Bank sold out of 10x Genomics (TXG) in Q2 2023, closing a stake of 22 shares — an estimated $1K sold.

Toronto Dominion Bank first reported a position in TXG in Q4 2020 and held it in 9 quarters. The position peaked at $2.13M in Q4 2021. 274 funds tracked by Wall St. Rank hold TXG as of Q2 2023.

  • Toronto Dominion Bank reported no remaining 10x Genomics position as of Q2 2023 after selling out during the quarter.
  • Toronto Dominion Bank sold 22 10x Genomics shares in Q2 2023, an estimated $1K.
  • Toronto Dominion Bank first reported a position in 10x Genomics in Q4 2020 and held it in 9 quarters.
  • Toronto Dominion Bank's 10x Genomics position peaked at $2.13M in Q4 2021.
  • 274 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2023.

Based on Toronto Dominion Bank's 13F filing for Q2 2023, filed 10 Aug 2023.